Restart Life Sciences Corp. Stock OTC Markets
Stocks
NMLSF
CA76134J2065
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0556 USD | -18.16% |
|
0.00% | -35.72% |
| Market Cap | 5.3M 3.76M 3.3M 3.07M 2.83M 359M 5.39M 36.47M 14.28M 178M 14.12M 13.82M 616M | P/E 2024 |
6x | P/E 2025 | -3.05x |
|---|---|---|---|---|---|
| Enterprise Value | 3.89M 2.76M 2.42M 2.26M 2.08M 264M 3.96M 26.79M 10.49M 131M 10.37M 10.15M 452M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
93.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -18.16% | ||
| Current month | -7.33% | ||
| 1 month | -44.06% | ||
| 3 months | -55.23% | ||
| 6 months | -29.62% | ||
| Current year | -35.72% |
| 1 month | 0.02 |  | 0.07 |
| Current year | 0.01 | | 0.12 |
| 1 year | 0.01 | | 0.12 |
| 3 years | 0.01 | | 0.28 |
| 5 years | 0.01 | | 1.26 |
| 10 years | 0.01 | | 32.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steve Loutskou
CEO | Chief Executive Officer | - | 22/10/2024 |
Inez Ho
DFI | Director of Finance/CFO | 42 | 03/06/2026 |
Kelly Pladson
ADM | Chief Administrative Officer | 44 | 01/02/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Georg Hochwimmer
BRD | Director/Board Member | 58 | 03/01/2024 |
Steve Loutskou
CHM | Chairman | - | 22/10/2024 |
| Director/Board Member | - | 10/12/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -18.16% | 0.00% | - | - | 3.68M | |
| +0.59% | +4.92% | -3.00% | +11.40% | 47.88B | |
| -2.24% | +0.31% | +393.45% | +615.13% | 39.09B | |
| +1.40% | +3.69% | +12.21% | +46.79% | 36.75B | |
| +13.94% | +20.49% | +22.85% | +7.42% | 40.55B | |
| -0.73% | +3.38% | +4.94% | +41.45% | 27.96B | |
| +0.40% | -0.30% | - | - | 16.77B | |
| -3.12% | +7.39% | +26.03% | +124.08% | 15.94B | |
| -1.14% | -4.02% | +1.86% | +8.25% | 13.55B | |
| +6.79% | +8.17% | -4.97% | -28.52% | 13.81B | |
| Average | -0.22% | +4.64% | +56.67% | +103.25% | 28.03B | |
| Weighted average by Cap. | +2.27% | +5.03% | +72.69% | +125.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | 225K 160K 140K 130K 120K 15.24M 229K 1.55M 605K 7.56M 599K 586K 26.11M | -1.39M -987K -866K -806K -742K -94.28M -1.41M -9.57M -3.75M -46.76M -3.7M -3.62M -162M |
| Net Debt | -86.02K -61.05K -53.58K -49.89K -45.89K -5.83M -87.5K -592K -232K -2.89M -229K -224K -9.99M | -1.41M -999K -876K -816K -751K -95.41M -1.43M -9.68M -3.79M -47.32M -3.75M -3.67M -163M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- HEAL Stock
- NMLSF Stock
Select your edition
All financial news and data tailored to specific country editions
